# Mode of Action of Moviprep

> **NCT01622972** · PHASE4 · COMPLETED · sponsor: **University of Nottingham** · enrollment: 72 (actual)

## Conditions studied

- Functional Constipation
- Irritable Bowel Syndrome Characterized by Constipation

## Interventions

- **DRUG:** Polyethyleneglycol

## Key facts

- **NCT ID:** NCT01622972
- **Lead sponsor:** University of Nottingham
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2014-02
- **Final completion:** 2014-02
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2014-04-14

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01622972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01622972, "Mode of Action of Moviprep". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT01622972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*